Cherity Burrows, APRN-CNP

NPI: 1285977801
Total Payments
$284.09
2024 Payments
$100.10
Companies
11
Transactions
16
Medicare Patients
1,096
Medicare Billing
$46,217

Payment Breakdown by Category

Food & Beverage$284.09 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $284.09 16 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $65.21 3 $0 (2024)
GlaxoSmithKline, LLC. $55.37 4 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $22.32 1 $0 (2022)
Xeris Pharmaceuticals, Inc. $22.27 1 $0 (2023)
AstraZeneca Pharmaceuticals LP $21.91 1 $0 (2024)
Axsome Therapeutics, Inc. $19.24 1 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $17.07 1 $0 (2022)
Lilly USA, LLC $16.45 1 $0 (2022)
Lundbeck LLC $15.69 1 $0 (2023)
Exact Sciences Corporation $15.29 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $100.10 6 AstraZeneca Pharmaceuticals LP ($21.91)
2023 $85.45 5 GlaxoSmithKline, LLC. ($27.98)
2022 $98.54 5 ABBVIE INC. ($28.46)

All Payment Transactions

16 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/16/2024 ABBVIE INC. VIBERZI (Drug) Food and Beverage In-kind items and services $17.24 General
Category: GASTROENTEROLOGY
11/06/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $19.24 General
Category: Psychology/Psychiatric
10/16/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $21.91 General
Category: Respiratory
08/07/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.15 General
Category: RESPIRATORY
05/08/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $13.27 General
Category: Cardiology/Vascular Diseases
01/04/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $15.29 General
Category: Oncology
12/06/2023 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $15.69 General
Category: PSYCHIATRY
07/18/2023 Xeris Pharmaceuticals, Inc. GVOKE HYPOPEN (Drug) Food and Beverage In-kind items and services $22.27 General
Category: Diabetes
03/22/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.38 General
Category: RESPIRATORY
03/02/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $19.51 General
Category: NEUROSCIENCE
01/30/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.60 General
Category: RESPIRATORY
10/18/2022 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $16.45 General
Category: Diabetes
10/06/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.24 General
Category: RESPIRATORY
07/26/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $22.32 General
Category: DIABETES
07/13/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $28.46 General
Category: NEUROSCIENCE
03/09/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $17.07 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 664 1,674 $87,484 $26,461
2022 10 432 859 $53,794 $19,756
Total Patients
1,096
Total Services
2,533
Medicare Billing
$46,217
Procedure Codes
24

All Medicare Procedures & Services

24 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 154 391 $49,989 $18,672 37.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 26 26 $4,665 $2,548 54.6%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 40 46 $4,600 $1,593 34.6%
96372 Injection of drug or substance under skin or into muscle Office 2023 81 188 $8,460 $1,357 16.0%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2023 27 62 $3,224 $1,006 31.2%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2023 39 43 $1,376 $332.24 24.1%
36415 Insertion of needle into vein for collection of blood sample Office 2023 30 36 $360.00 $302.40 84.0%
G0008 Administration of influenza virus vaccine Office 2023 11 11 $275.00 $269.50 98.0%
81002 Urinalysis, manual test Office 2023 25 37 $370.00 $126.17 34.1%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2023 46 268 $5,360 $91.10 1.7%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 64 85 $1,700 $58.91 3.5%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2023 37 49 $1,225 $51.44 4.2%
J1885 Injection, ketorolac tromethamine, per 15 mg Office 2023 22 104 $2,600 $28.52 1.1%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 62 328 $3,280 $25.71 0.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 147 263 $33,664 $14,788 43.9%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2022 37 39 $3,900 $1,569 40.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 21 21 $3,285 $1,437 43.7%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2022 29 65 $3,380 $1,024 30.3%
96372 Injection of drug or substance under skin or into muscle Office 2022 57 89 $4,005 $695.54 17.4%
81002 Urinalysis, manual test Office 2022 22 29 $290.00 $99.17 34.2%
36415 Insertion of needle into vein for collection of blood sample Office 2022 17 19 $190.00 $55.95 29.4%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2022 27 132 $2,640 $41.43 1.6%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2022 39 42 $840.00 $32.68 3.9%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2022 36 160 $1,600 $13.21 0.8%

About Cherity Burrows, APRN-CNP

Cherity Burrows, APRN-CNP is a Family healthcare provider based in Altus, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2013. The National Provider Identifier (NPI) number assigned to this provider is 1285977801.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cherity Burrows, APRN-CNP has received a total of $284.09 in payments from pharmaceutical and medical device companies, with $100.10 received in 2024. These payments were reported across 16 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($284.09).

As a Medicare-enrolled provider, Burrows has provided services to 1,096 Medicare beneficiaries, totaling 2,533 services with total Medicare billing of $46,217. Data is available for 2 years (2022–2023), covering 24 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Altus, OK
  • Active Since 04/02/2013
  • Last Updated 10/26/2016
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1285977801

Products in Payments

  • TRELEGY ELLIPTA (Drug) $55.37
  • JARDIANCE (Drug) $38.77
  • UBRELVY (Drug) $28.46
  • GVOKE HYPOPEN (Drug) $22.27
  • AIRSUPRA (Drug) $21.91
  • VRAYLAR (Drug) $19.51
  • Auvelity (Drug) $19.24
  • VIBERZI (Drug) $17.24
  • TRINTELLIX (Drug) $17.07
  • REXULTI (Drug) $15.69
  • Cologuard Collection Kit (Device) $15.29
  • LEQVIO (Drug) $13.27

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Altus